Last updated: 1 August 2019 at 8:07am EST

John Hlywak Net Worth




The estimated Net Worth of John Hlywak is at least $2.13 Milion dollars as of 15 December 2008. John Hlywak owns over 3,000 units of Inmode Ltd stock worth over $1,719,491 and over the last 22 years John sold INMD stock worth over $414,750.

John Hlywak INMD stock SEC Form 4 insiders trading

John has made over 16 trades of the Inmode Ltd stock since 2004, according to the Form 4 filled with the SEC. Most recently John bought 3,000 units of INMD stock worth $18,450 on 15 December 2008.

The largest trade John's ever made was selling 24,000 units of Inmode Ltd stock on 15 August 2005 worth over $213,600. On average, John trades about 3,415 units every 60 days since 2003. As of 15 December 2008 John still owns at least 101,745 units of Inmode Ltd stock.

You can see the complete history of John Hlywak stock trades at the bottom of the page.



What's John Hlywak's mailing address?

John's mailing address filed with the SEC is , , , , .

Insiders trading at Inmode Ltd

Over the last 21 years, insiders at Inmode Ltd have traded over $6,777,953 worth of Inmode Ltd stock and bought 2,728,596 units worth $21,820,912 . The most active insiders traders include Peter R Kellogg, Capital Partners, L.P.Sagar... a & Mcbaine Capital Managemen.... On average, Inmode Ltd executives and independent directors trade stock every 14 days with the average trade being worth of $289,649. The most recent stock trade was executed by Yvonne Thornton on 2 July 2012, trading 500 units of INMD stock currently worth $6,895.



What does Inmode Ltd do?

inmode offers the most exciting and effective aesthetic solutions with fractora, forma/plus, lumeccca, diolaze and bodyfx. fractora: bipolar radio-frequency fractional treatment for superior improvements in texture, wrinkles, acne scars and contraction. lumecca: broad spectrum pulsed light for rejuvenation of photo-damaged skin in a wide variety of skin types. diolaze: ultra fast diode hair removal featuring simultaneous 3pc (pre, parallel, and post cooling) technology and state of the art pulsing and power. bodyfx: non-invasive body contouring for buttocks, abdomen, flanks and thighs with a.c.e. technology



What does Inmode Ltd's logo look like?

Inmode Ltd logo

Complete history of John Hlywak stock trades at Inmode Ltd

Datum
#
Společnost
Osoba
Trans.
Transakce
Počet akcií Cena za akcii Celková cena Počet akcií po Zdroj
15 Dec 2008 John Hlywak
Sr. VP a Chief Financial Off
Koupě 3,000 $6.15 $18,450
15 Dec 2008
101,745
12 Dec 2008 John Hlywak
Sr. VP a Chief Financial Off
Koupě 2,000 $6.15 $12,300
12 Dec 2008
98,745
11 Dec 2008 John Hlywak
Sr. VP a Chief Financial Off
Koupě 5,000 $6.06 $30,300
11 Dec 2008
96,745
10 Dec 2008 John Hlywak
Sr. VP a Chief Financial Off
Koupě 2,000 $5.77 $11,540
10 Dec 2008
91,745
7 Nov 2008 John Hlywak
Sr. VP a Chief Financial Off
Koupě 1,100 $6.19 $6,809
7 Nov 2008
89,745
5 Nov 2008 John Hlywak
Sr. VP a Chief Financial Off
Koupě 1,000 $5.66 $5,660
5 Nov 2008
88,645
4 Nov 2008 John Hlywak
Sr. VP a Chief Financial Off
Koupě 900 $5.85 $5,265
4 Nov 2008
87,645
4 Nov 2008 John Hlywak
Sr. VP a Chief Financial Off
Koupě 1,000 $5.48 $5,480
4 Nov 2008
86,745
31 Oct 2008 John Hlywak
Sr. VP a Chief Financial Off
Koupě 1,000 $5.14 $5,140
31 Oct 2008
85,745
4 Jun 2008 John Hlywak
Sr. VP a Chief Financial Off
Koupě 1,000 $7.87 $7,870
4 Jun 2008
84,745
16 Nov 2007 John Hlywak
Sr. VP a Chief Financial Off
Prodej 15,000 $13.41 $201,150
16 Nov 2007
81,634
15 Nov 2006 John Hlywak
Sr. VP a Chief Financial Off
Využití opce 9,063 $3.68 $33,352
15 Nov 2006
76,083
9 Sep 2005 John Hlywak
Sr. VP a Chief Financial Off
Využití opce 4,554 $4.09 $18,626
9 Sep 2005
52,704
15 Aug 2005 John Hlywak
Sr. VP a Chief Financial Off
Prodej 24,000 $8.90 $213,600
15 Aug 2005
48,150
28 Dec 2004 John Hlywak
Sr. VP a Chief Financial Off
Využití opce 8,420 $4.50 $37,890
28 Dec 2004
56,420
24 Mar 2004 John Hlywak
Sr. VP a Chief Financial Off
Využití opce 20,000 $4.50 $90,000
24 Mar 2004
58,120


Inmode Ltd executives and stock owners

Inmode Ltd executives and other stock owners filed with the SEC include: